idarubicin has been researched along with Digestive System Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, R; Green, M; Hochster, H; Liebes, L; Muggia, F; Speyer, JL; Wernz, J | 1 |
1 other study(ies) available for idarubicin and Digestive System Neoplasms
| Article | Year |
|---|---|
Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacology.
Topics: Adult; Aged; Digestive System Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Half-Life; Hematologic Diseases; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms | 1990 |